RECOVERY Collaborative Group 2023, ' Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. ', Lancet (London, England), vol. 401, no. 10387, pp. 1499-1507 . https://doi.org/10.1016/S0140-6736(23)00510-X
BJS open r-FISABIO. Repositorio Institucional de Producción Científica instname STARSurg Collaborative and EuroSurg Collaborative 2022, ' Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery ', BJS Open, vol. 6, no. 1, zrab150 . https://doi.org/10.1093/bjsopen/zrab150 BJS open, 6(1):zrab150. John Wiley & Sons Ltd. BJS OPEN Ahmed, W, Bhatia, S, Mclean, K, Khaw, R A, Baker, D E A, Kamarajah, S K, Bell, S, Nepogodiev, D, Harrison, E M & Glasbey, J C 2022, ' Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery ', BJS Open . https://doi.org/10.1093/bjsopen/zrab150 BJS Open, 6 BJS Open, 6(1):zrab150. John Wiley & Sons Inc. BJS Open, 6, 1 BJS open, 6(1):zrab150. BMJ PUBLISHING GROUP STARSurg Collaborative and EuroSurg Collaborative, Kjaer, M D, Unbehaun, K P & Mark-Christensen, A 2022, ' Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery ', BJS open, vol. 6, no. 1, zrab150 . https://doi.org/10.1093/bjsopen/zrab150 BJS Open r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe BJS Open, 6(1). OXFORD UNIV PRESS r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Mumford, A D & Gibbison, B J J 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet, vol. 400, no. 10349, pp. 359-368 . https://doi.org/10.1016/S0140-6736(22)01109-6 Dimitriadis, G K 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet, vol. 400, no. 10349, pp. 359-368 . https://doi.org/10.1016/S0140-6736(22)01109-6 RECOVERY Collaborative Group & Dark, P 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet . https://doi.org/10.1016/S0140-6736(22)01109-6
Lancet (London, England) LANCET RECOVERY Collaborative Group 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) a randomised controlled, open-label, platform trial ', The Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Mumford, A D 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised controlled, open-label, platform trial ', Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Group, RECOVERY C & Dark, P 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. ', Lancet (London, England), vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7